4-[Hydroxy-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)methyl]benzoic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 英文名称: 4-[Hydroxy-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)methyl]benzoic acid
• 化学式: C₂₃H₂₈O₃
• 分子量: 352.5
• InChiKey: JXFKMUMLVKCFHN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  26
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
  申请人：Boehm F. Marcus

  公开号：US20060106072A1

  公开（公告）日：2006-05-18

  Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, and pyrrole derivatives. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.

  本发明涉及利用类视黄醇化合物调节由视黄酸X受体介导的过程的复合物、组合物和方法，其中这些类视黄醇化合物具有对视黄酸X受体亚类（RXRs）的选择性活性，而不是对视黄酸受体亚类（RARs）的选择性活性。此类化合物的例子包括双环苄基、吡啶基、噻吩基、呋喃基和吡咯基衍生物。所披露的方法利用这些化合物来调节由视黄酸X受体选择性介导的过程。
• Compounds having selectivity for retinoid x receptors
  申请人：LIGAND PHARMACEUTICALS, INC.

  公开号：EP0983991A2

  公开（公告）日：2000-03-08

  Compounds, compositions, and method for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, and pyrrole derivatives. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.

  利用对视黄醇 X 受体（RXRs）亚类成员具有选择性活性的视黄醇样化合物，优先于视黄酸受体（RARs）亚类成员，调节视黄醇 X 受体介导的过程的化合物、组合物和方法。此类化合物的例子有双环苄基、吡啶基、噻吩基、呋喃基和吡咯衍生物。所公开的方法采用化合物来调节由视黄酸 X 受体选择性介导的过程。
• COMPOUNDS HAVING SELECTIVITY FOR RETINOID X RECEPTORS
  申请人：LIGAND PHARMACEUTICALS, INC.

  公开号：EP0637297A1

  公开（公告）日：1995-02-08
• EP0637297A4
  申请人：——

  公开号：EP0637297A4

  公开（公告）日：1995-09-20
• COMPOUNDS HAVING SELECTIVE ACTIVITY FOR RETINOID X RECEPTORS, AND MEANS FOR MODULATION OF PROCESSES MEDIATED BY RETINOID X RECEPTORS
  申请人：LIGAND PHARMACEUTICALS, INC.

  公开号：EP0678087B1

  公开（公告）日：1999-03-17